Series C · Consumer

OrbiMed backs Pee Safe in $32 million primary and secondary deal

The hygiene brand plans to expand retail distribution and online sales channels.

Pee Safe announced a $32 million transaction with OrbiMed on 14 January 2026. The deal combines new investment and secondary share sales; the company did not disclose the amount of fresh capital.

The personal hygiene brand plans to expand offline distribution, strengthen marketing and increase its presence on quick commerce platforms and marketplaces.

Pee Safe’s portfolio spans toilet hygiene, menstrual and intimate care, grooming and sexual wellness. Transaction counsel said the primary investment was structured in three tranches.

Use of funds

Offline retail distribution

Brand marketing

Quick commerce and marketplaces

Funding history

Series C · This roundUndisclosed
Series B partial close$3M

Sources

  1. Original investment announcementeconomictimes.indiatimes.com · Jan 14, 2026
  2. Original investment announcementmondaq.com · Jan 23, 2026